nach oben

Nuclear Medicine and Molecular Imaging

Erschienen in:

14.02.2024 | Case Report

Annotating the Role of ¹⁸F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies—Is It Really an Advantageous Tool?

verfasst von: Srinivas Ananth Kumar, Harmandeep Singh, Lileswar Kaman, Ritambhra Nada, Bhagwant Rai Mittal

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Fibromatoses are a heterogeneous group of benign proliferating fibroblasts and myofibroblasts which have a high predilection for recurrence and local invasion, especially deep fibromatoses or desmoid fibromatosis. ¹⁸F-FDG PET/CT, the workhorse of oncological imaging in nuclear medicine, can be employed to figure out the nature and aggressiveness of the lesions and various sites of involvement and to monitor treatment response to systemic therapies like tyrosine kinase inhibitors in case of deep or desmoid fibromatoses which is shown in the current research work.

Lacka DE, Nasierowska-Guttmejer A. Fibromatosis - immunohistochemical evaluation, differential diagnosis from gastrointestinal tumors, and other mesenchymal tumours. Prz Gastroenterol. 2019;14:79–85.PubMedPubMedCentral

Walker EA, Petscavage JM, Brian PL, Logie CI, Montini KM, Murphey MD. Imaging features of superficial and deep fibromatoses in the adult population. Sarcoma. 2012;2012: 215810.CrossRefPubMedPubMedCentral

DeVita VT Jr, Lawrence TS, Rosenberg SA, et al. DeVita, Hellman, and Rosenberg’s cancer: principles and practice of oncology, vol. 2, chapter 45, Lippincot Williams and Wilkins, 8th edition. 2008.

Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoid tumour. Am J Surg. 1986;151:230–7.CrossRefPubMed

Ganeshan D, Amini B, Nikolaidis P, Assing M, Vikram R. Current update on desmoid fibromatosis. J Comput Assist Tomogr. 2019;43:29–38.CrossRefPubMedPubMedCentral

Zhang Z, Shi J, Yang T, Liu T, Zhang K. Management of aggressive fibromatosis. Oncol Lett. 2021;21:43.PubMed

Li Destri G, Ferraro MJ, Calabrini M, Pennisi M, Magro G. Desmoid-type fibromatosis of the mesentery: report of a sporadic case with emphasis on differential diagnostic problems. Case Rep Med. 2014;2014:850180.

Abdalla S, Wilkinson M, Wilsher M, Uzkalnis A. An atypical presentation of small bowel obstruction and perforation secondary to sporadic synchronous intra-abdominal desmoid tumours. Int J Surg Case Rep. 2016;20:147–50.CrossRefPubMedPubMedCentral

Robbin MR, Murphey MD, Temple HT, Kransdorf MJ, Choi JJ. Imaging of musculoskeletal fibromatosis. Radiographics. 2001;21:585–600.CrossRefPubMed

10.

Xu H, Koo HJ, Lim S, Lee JW, Lee HN, Kim DK, et al. Desmoid-type fibromatosis of the thorax: CT, MRI, and FDG PET characteristics in a large series from a tertiary referral center. Medicine (Baltimore). 2015;94(38): e1547.CrossRefPubMed

11.

Winiarczyk N, Beam A, Aird G, Broski S. 18F-FDG PET/CT evaluation of desmoid fibromatosis. J Nucl Med. 2021;63:177–177.

12.

Kumar SS, Rajeevan K, Devarajan E. Desmoid-type fibromatosis-clinical study of an uncommon disease. Indian J Surg Oncol. 2020;11:71–4.CrossRefPubMed

13.

Alshammari A, Ashkanani R, Alabsi S, Ghanem M. Gardner syndrome with extra and intra-abdominal desmoid tumors and adrenal involvement: PET/CT findings. Case Rep Mol Imaging Radionucl Ther. 2015;24:38–41.CrossRef

14.

Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, Tirumani SH, Shinagare AB, Hornick JL, et al. Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists. Radiographics. 2016;36:767–82.CrossRefPubMed

15.

Kasper B, Dimitrakopoulou-Strauss A, Strauss LG, Hohenberger P. Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib. Eur J Nucl Med Mol Imaging. 2010;37:1876–82.CrossRefPubMed

16.

Souza FF, Fennessy FM, Yang Q, van den Abbeele AD. Case report. PET/CT appearance of desmoid tumour of the chest wall. Br J Radiol. 2010;83:e39-42.CrossRefPubMed

17.

Choi KA, An YY. Desmoid tumor of the chest wall mimicking recurrent breast cancer: multimodality imaging findings. Iran J Radiol. 2016;13: e31649.CrossRefPubMedPubMedCentral

18.

Kawashima K, Hiramatsu K, Kato T, Fukaya M, Aoba T, Arimoto A, et al. A desmoid tumor with fluorodeoxyglucose accumulation arising from the anastomotic site of postoperative gastric cancer: a case report. J Med Case Rep. 2022;16:423.CrossRefPubMedPubMedCentral

19.

Mizuno M, Kawaguchi Y, Kawanishi A, Kawashima Y, Maruno A, Ogawa M, et al. An intra-abdominal desmoid tumor, embedded in the pancreas, preoperatively diagnosed as an extragastric growing gastrointestinal stromal tumor. Case Rep Oncol. 2017;10:301–7.CrossRefPubMedPubMedCentral

20.

Suzumura K, Kondo Y, Okada T, Iimuro Y, Kuroda N, Torii I, et al. A case of an intra-abdominal desmoid tumor with FDG uptake on PET. J Jpn Surg Assoc. 2014;75:573–8.CrossRef

21.

Makis W, Ciarallo A, Abikhzer G, Stern J, Laufer J. Desmoid tumour (aggressive fibromatosis) of the colon mimics malignancy on dual time-point 18F-FDG PET/CT imaging. Br J Radiol. 2012;85:e37-40.CrossRefPubMed

22.

Nishio J, Aoki M, Nabeshima K, Iwasaki H, Naito M. Imaging features of desmoid-type fibromatosis in the teres major muscle. In Vivo. 2013;27:555–9.PubMed

23.

Kumar JN, Indirani M, Sampathirao N, Shelley S. Fibromatosis with aggressive demeanor: benign impersonator of malignancy. World J Nucl Med. 2020;20:121–4.PubMedPubMedCentral

24.

Thakore KJ, Hudson TM, Monson DK, Scheidt KA. Triple-phase bone scan findings in aggressive fibromatosis. Before and after radiation therapy. Clin Nucl Med. 1994;19:197–203.CrossRefPubMed

25.

Kanthan GL, Hsiao E, Kneebone A, Eade T, Schembri GP. Desmoid tumor showing intense uptake on 68Ga PSMA-HBED-CC PET/CT. Clin Nucl Med. 2016;41:508–9.CrossRefPubMed

26.

Friesenbichler J, Molcan A, Aigner R, Sadoghi P, Liegl-Atzwanger B, Maurer-Ertl W, et al. The role of somatostatin receptor scintigraphy on the diagnosis of desmoid tumors. ISRN Oncol. 2012;2012: 167545.PubMedPubMedCentral

27.

De Pas T, Bodei L, Pelosi G, De Braud F, Villa G, Capanna R, et al. Italian Sarcoma Group. Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group. Br J Cancer. 2003;88:645–7.CrossRefPubMedPubMedCentral

Titel: Annotating the Role of 18F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies—Is It Really an Advantageous Tool?
verfasst von: Srinivas Ananth Kumar
Harmandeep Singh
Lileswar Kaman
Ritambhra Nada
Bhagwant Rai Mittal
Publikationsdatum: 14.02.2024
Verlag: Springer Nature Singapore
Erschienen in: Nuclear Medicine and Molecular Imaging / Ausgabe 3/2024
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI: https://doi.org/10.1007/s13139-024-00846-5

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2024

Contribution of ChatGPT in Parkinson’s Disease Detection

Association Between 18F-FDG PET Activity and HER2 Status in Breast Cancer Brain Metastases

Discordant Molecular Imaging Findings with 2-[18F]FDG and [68Ga]Ga-PSMA PET/CT in a Patient with Both Bladder and Prostate Cancer

Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method

Incidentally Detected Gallbladder Carcinoma: Can F-18 FDG PET/CT Aid in Staging and Prognostication?

Recent Updates on Applications of Artificial Intelligence for Nuclear Medicine Professionals: Prostate Cancer and PET/CT